Anxiety Disorders Completed Phase 1 / 2 Trials for Mifepristone (DB00834)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01333098Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety DisordersTreatment